Aradigm

Grifols
Biotech

Grifols buys antibiotic assets from bankrupt partner Aradigm

The agreement sees Grifols waive a $32 million debt and pay $3 million in cash to take full ownership of three assets.
Nick Paul Taylor Feb 24, 2020 8:57am
Lungs

End of the line looms for Aradigm as it files for bankruptcy

Feb 19, 2019 10:46am
Exit sign on floor amid wreckage

Aradigm executives jump ship after FDA snub

Feb 14, 2018 11:15am
FDA

FDA demands 2-year phase 3 from Aradigm

Jan 29, 2018 10:47am
fda

Aradigm crashes after FDA panel votes down antibiotic

Jan 12, 2018 6:29am